This cheap pantry staple could be key to lowering cholesterol, new research suggests
A common pantry staple may be the secret to lowering cholesterol levels, according to a new study.
Researchers at the Illinois Institute of Technology found that chickpeas, also called garbanzo beans, can have cholesterol-lowering qualities.
Participants who consumed a cup of chickpeas daily for 12 weeks experienced a significant reduction in their elevated cholesterol levels.
The research, which involved adults with prediabetes, was presented at the NUTRITION 2025 conference in Orlando last week.
Researchers also studied the effects of daily black bean consumption but found these were not as effective as chickpeas.
Dr. William W. Li, author of the book "Eat to Beat Disease: The New Science of How Your Body Can Heal Itself," broke down the research in an interview with Fox News Digital. (He was not involved in the study.)
Li said chickpeas can reduce cholesterol levels through the gut biome, which contains trillions of bacteria.
"The way chickpeas work is by providing dietary fiber, which improves and activates the gut microbiome," Li said.
"They can be dried and roasted and eaten as a snack."
"Among their many functions, well-fed healthy bacteria, fed by chickpeas, improve lipid metabolism, which lowers blood cholesterol. And they lower inflammation by releasing metabolites called short-chain fatty acids."
While it may seem daunting to incorporate a cup of chickpeas every day, Li said there are plenty of tasty recipes out there.
Chickpeas, he said, "can be dried and roasted and eaten as a snack."
"They can be stewed along with spices and onions and other vegetables for a hearty and healthy meal."
While there are many ways to cook chickpeas, taking a healthy approach to them is crucial, said Li.
Consumers should avoid using excessive oil while cooking the legume and stay away from deep frying.
Instead, he said, roasting, stewing or simmering chickpeas are great ways to cook them while maintaining their nutritional benefits.
"Use healthy oils to cook them, like extra virgin olive oil," Li said. "Add other healthy ingredients, like onions, garlic and turmeric to enhance the health benefits of the dish."
Popular ways to cook chickpeas include preparing them into falafel, dropping them into salads or using them as a vegetarian protein alternative in tuna salad recipes.
Hummus, one of the most popular uses of chickpeas, is a tasty, savory dip that originates from the Middle East.
Cooking experts advise removing the skin from chickpeas before preparing hummus.
Other ingredients in the dish include tahini, garlic, olive oil and a variety of spices.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
3 days ago
- New York Post
Bill Gates shares ‘next phase of Alzheimer's fight' as he speaks about his father's personal battle
Bill Gates is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. In an essay published this week on his blog at the Microsoft co-founder and tech billionaire, 69, reflected on the difficulty of spending another Father's Day without his dad, Bill Gates Sr. Advertisement The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. 'It was a brutal experience, watching my brilliant, loving father go downhill and disappear,' Gates wrote in the blog post. Today, motivated by his own experience with the common dementia, Gates — who serves as chair of the Gates Foundation — is committed to working toward a cure for the common dementia, which currently affects more than seven million Americans, or one in nine people over 65. In his blog, Gates expressed optimism about the 'massive progress' being made in the fight against Alzheimer's and other dementias. Advertisement Last year, Gates said he visited Indiana University's School of Medicine in Indianapolis to tour the labs where teams have been researching Alzheimer's biomarkers. 5 Bill Gates (left) is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. Brian Ach 'I also got the opportunity to look under the hood of new automated machines that will soon be running diagnostics around the world,' he wrote. 'It's an exciting time in a challenging space.' One of the biggest breakthroughs in Alzheimer's research, according to Gates, is blood-based diagnostic tests, which detect the ratio of amyloid plaques in the brain. (Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer's.) Advertisement 'I'm optimistic that these tests will be a game-changer,' Gates wrote. 5 The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. Bloomberg via Getty Images Last month, the U.S. Food and Drug Administration (FDA) approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. Traditionally, Gates noted, the primary path to Alzheimer's diagnosis was either a PET scan (medical imaging) or spinal tap (lumbar puncture), which were usually only performed when symptoms emerged. Advertisement The hope is that blood-based tests could do a better job of catching the disease early, decline begins. 5 Last month, the U.S. Food and Drug Administration approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. – 'We now know that the disease begins 15 to 20 years before you start to see any signs,' Gates wrote. 'A simple, accurate and easy-to-run blood test might one day make routine screening possible, identifying patients long before they experience cognitive decline,' he stated. Gates said he is often asked, 'What is the point of getting diagnosed if I can't do anything about it?' Start and end your day informed with our newsletters Morning Report and Evening Update: Your source for today's top stories Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters To that end, he expressed his optimism for the future of Alzheimer's treatments, noting that two drugs — Lecanemab (Leqembi) and Donanemab (Kisunla) — have gained FDA approval. 'Both have proven to modestly slow down the progression of the disease, but what I'm really excited about is their potential when paired with an early diagnostic,' Gates noted. Advertisement He said he is also hopeful that the blood tests will help speed up the process of enrolling patients in clinical trials for new Alzheimer's drugs. 5 The hope is that blood-based tests could do a better job of catching the disease early, decline begins. Monkey Business – To accomplish this, Gates is calling for increased funding for research, which often comes from federal grants. 'This is the moment to spend more money on research, not less,' he wrote, also stating that 'the quest to stop Alzheimer's has never had more momentum.' Advertisement 'There is still a huge amount of work to be done — like deepening our understanding of the disease's pathology and developing even better diagnostics,' Gates went on. 5 Microsoft Chairman Bill Gates, his wife Melinda, far left, his father Bill Gates Sr., and his step-mother Mimi Gates pose for a photo in 2007. AP Gates pointed out that when his father had Alzheimer's, it was considered a 'death sentence,' but that is starting to change. Advertisement 'I am blown away by how much we have learned about Alzheimer's over the last couple of years,' he wrote. 'I cannot help but be filled with a sense of hope when I think of all the progress being made on Alzheimer's, even with so many challenges happening around the world. We are closer than ever before to a world where no one has to watch someone they love suffer from this awful disease.'
Yahoo
4 days ago
- Yahoo
VA secretary calls out California officials after LA anti-ICE riots shutter clinic serving veterans
Veterans Affairs Secretary Doug Collins called out California officials for ignoring the impact the Los Angeles anti-ICE riots have had on displaced veterans after an ambulatory clinic was forced to suddenly shutter its doors earlier this month. "They're not peaceful. We see what they're doing. They're throwing stuff at us. They're taking it out on the police," he said of the protesters on "Fox & Friends," Wednesday. "What Gavin Newsom and… the mayor, don't want to talk about is the impact on the people who are just trying to live their lives… we have a large homeless population of veterans [in Los Angeles]… which we're working on fixing… but we've got a lot who just need that basic care." Exclusive: Va Dept Says La Riots Forced Community Center Closures Impacting More Than 600 Veterans Collins said the local benefits office is also closed, meaning veterans are struggling to receive the help they need in multiple ways. He also said workers have been displaced as a result of the chaos. Read On The Fox News App "Nobody talks about that… the governor out there and the mayor – why don't they actually talk about the real issue, and that's that we can't get services to the people that need it?" The now-closed Los Angeles VA clinic provided cancer care, suicide prevention, pain management, amputation care and traumatic brain injury services. Maxine Waters Taunts Armed Agents After Feds Slam Door On Her During La Riots: 'You Better Shoot Straight' Collins said the VA has transferred as many patients as possible to telehealth services to continue their care, but says there's little substitute for traditional treatment. "I'm tired of this idea that we're trying to help our veterans, help Americans, but yet we're letting the folks in L.A. run wild and graffiti our buildings and do the things that stop us from actually taking care of our veterans," he said. Fox News Digital reached out to the offices of Gov. Gavin Newsom and Mayor Karen Bass for a prior report on this issue. Fox News Digital's Charles Creitz contributed to this article source: VA secretary calls out California officials after LA anti-ICE riots shutter clinic serving veterans
Medscape
4 days ago
- Medscape
Diabetes Plus Asthma Equals Greater Metabolic Risk
People with both diabetes and asthma appear to face greater metabolic risks than those with either condition alone, according to new observational data. In a study of more than 18,000 participants from the National Health and Nutrition Examination Survey during 2001-2020, individuals with both asthma and diabetes (most presumed to have type 2 diabetes) had significantly greater impairments in glucose regulation, insulin sensitivity, and lipid metabolism compared with those who had only one condition alone or neither. Inflammatory markers C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP) were also elevated in the comorbid group, 'supporting a hypothesis of a shared inflammatory mechanism,' Sixtus Aguree, PhD, assistant professor at the Indiana University School of Public Health-Bloomington, and colleagues wrote in a poster presented at NUTRITION 2025, the annual meeting of the American Society for Nutrition. The findings 'emphasize the need for integrated clinical strategies that simultaneously target both inflammation and metabolic dysfunction in patients with asthma-diabetes comorbidity,' the authors wrote. 'Routine screening for insulin resistance and inflammatory markers in [these] patients may aid in early intervention and risk reduction.' This points to the need for integrated clinical care, Aguree told Medscape Medical News . 'For managing these comorbid conditions, healthcare professionals need to work together. I think that's a better way to treat the person than working in silos.' Bidirectional Relationship Commenting on the findings, Tianshi David Wu, MD, assistant professor of pulmonary and critical care at Baylor College of Medicine in Houston, told Medscape Medical News that these findings align with current evidence. 'Diabetes and asthma have a bidirectional relationship,' Wu explained. 'Population studies have shown that patients with diabetes are at higher risk of developing asthma later on, and vice versa. What's still unknown are the mechanisms that explain this finding.' Wu added that the researchers had put forth a reasonable hypothesis — that systemic inflammation may play a key role in this association. 'The best way to prove this would be with a trial that specifically targets the type of inflammation you think is driving both asthma and diabetes to see how it affects these conditions.' As a possible blueprint, he pointed to cardiology, where patients with heart failure and diabetes are preferentially treated with sodium-glucose cotransporter-2 inhibitors, which are effective at treating both conditions. 'In the asthma world, I don't think the evidence is there yet to recommend any specific diabetes medication, but there is plenty of real-world data suggesting some benefit, and there are two clinical trials ongoing testing semaglutide and metformin to see if they can improve asthma,' Wu said. Surprising Impact on Insulin Resistance The study included 18,370 nationally representative US adults. Among them, 8.2% had diabetes without asthma, 7.4% had asthma without diabetes, 83.3% had neither (controls), and 1.2% had both. BMI was highest in the combined asthma-diabetes group (35.9 kg/m2 vs. 28.2 kg/m2 in controls, P < .001), as was waist circumference (117.6 cm vs. 97.3 cm, P < .001). Insulin resistance, defined as a homeostasis model assessment of insulin resistance (HOMA-IR) > 2.5, was present in 41% of controls, 46.8% with asthma only, 77.3% with diabetes only, and 85.6% with both conditions. The HOMA-IR score in the asthma-diabetes group was significantly higher than in controls (9.85 vs. 2.96, P < .001). Logistic regression analysis confirmed that the odds of insulin resistance were nearly eight times higher in the asthma-diabetes group than in the control group (odds ratio [OR], 7.89, P < .001), even after adjusting for BMI, sex, and medication use. 'We didn't expect insulin resistance to be that much higher in the combination of asthma and diabetes. That shocked us,' Aguree said. Asthma alone was not significantly associated with insulin resistance (OR, 0.76, P = .220), 'underscoring the additive impact of coexisting diabetes,' the authors wrote in their poster. Additional Metabolic Outcomes Absolute values of LDL cholesterol were 115.9 mg/dL and 114.5 mg/dL, respectively, for controls and asthma only, vs 98.9 mg/dL and 104.8 mg/dL for diabetes only and asthma-diabetes groups, respectively. The lower value in those with diabetes is likely due to greater use of statins, Aguree noted. In contrast, compared with controls, those in the asthma-diabetes group had significantly lower levels of HDL cholesterol, while triglycerides and the triglyceride/HDL ratio were higher ( P < .001 for all). Systolic blood pressure was also significantly higher in the comorbid group ( P < .001), as was diastolic blood pressure, although to a lesser extent ( P = .012). A1c levels were 5.41% in controls and 5.46% in the asthma-only group, both significantly lower than levels in the diabetes group (7.34%) and the comorbid group (7.11%), Aguree said. Log-CRP values were 0.530 units higher in the asthma-diabetes group than in controls ( P < .001), as were hs-CRP (1.70 mg/L vs 0.60 mg/L, P < .001). Aguree and colleagues are now expanding their analysis to include longitudinal data and evaluate integrated interventions, such as combined anti-inflammatory and glucose-lowering medications, as a means of reducing the burden of both conditions. Aguree had no disclosures. Wu declared receiving funding from the National Institutes of Health and the American Lung Association.
